Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

MonoGen closes equity capital bought deal private placement financing for an aggregate amount of US$7.5 million

Fasken
Reading Time 1 minute read Subscribe
Client

GMP Securities

On April 16, 2008, MonoGen, Inc. announced that it had closed on the previously announced equity capital bought deal private placement financing for an aggregate amount of $7.5 million, including the exercise of the underwriter's over-allotment option. GMP Securities L.P. was the underwriter for this financing. MonoGen, Inc., headquartered in the Chicago area, is a medical device and diagnostics company providing high-quality and cost-effective cytological screening and diagnostic products to healthcare providers in the anatomic pathology industry. GMP Securities was advised by a team from Fasken Martineau that included Rubin Rapuch, Georges Dubé and Karoline Kralka.

    Subscribe

    Receive email updates from our team

    Subscribe